Prime Medicine Management
Management criteria checks 2/4
Prime Medicine's CEO is Keith Gottesdiener, appointed in Jul 2020, has a tenure of 3.83 years. total yearly compensation is $924.04K, comprised of 58.7% salary and 41.3% bonuses, including company stock and options. directly owns 3.78% of the company’s shares, worth $21.46M. The average tenure of the management team and the board of directors is 1.8 years and 2.5 years respectively.
Key information
Keith Gottesdiener
Chief executive officer
US$924.0k
Total compensation
| CEO salary percentage | 58.7% |
| CEO tenure | 3.8yrs |
| CEO ownership | 3.8% |
| Management average tenure | 1.8yrs |
| Board average tenure | 2.5yrs |
Recent management updates
Recent updates
Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing
Jan 28Is Prime Medicine (NASDAQ:PRME) In A Good Position To Deliver On Growth Plans?
Aug 25
We're Not Very Worried About Prime Medicine's (NASDAQ:PRME) Cash Burn Rate
May 12Will Prime Medicine (NASDAQ:PRME) Spend Its Cash Wisely?
Jan 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$198m |
| Sep 30 2023 | n/a | n/a | -US$173m |
| Jun 30 2023 | n/a | n/a | -US$158m |
| Mar 31 2023 | n/a | n/a | -US$151m |
| Dec 31 2022 | US$924k | US$542k | -US$142m |
| Sep 30 2022 | n/a | n/a | -US$171m |
| Jun 30 2022 | n/a | n/a | -US$158m |
| Mar 31 2022 | n/a | n/a | -US$126m |
| Dec 31 2021 | US$3m | US$524k | -US$184m |
| Sep 30 2021 | n/a | n/a | -US$118m |
| Dec 31 2020 | US$935k | US$252k | -US$5m |
Compensation vs Market: Keith's total compensation ($USD924.04K) is below average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Keith's compensation has been consistent with company performance over the past year.
CEO
Keith Gottesdiener (69 yo)
3.8yrs
Tenure
US$924,044
Compensation
Dr. Keith Michael Gottesdiener, Ph D, serves as Venture Partner at Samsara Biocapital, LLC. He serves as the President & Secretary at Prime Medicine, Inc and also serves as a Director and Chief Executive O...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$924.04k | 3.78% $ 21.5m | |
| Chief Technical Officer | 2.6yrs | US$947.28k | 0% $ 0 | |
| Chief Business Officer | 1.8yrs | US$1.67m | 0% $ 0 | |
| Co-Founder & Head of Prime Editing Platform | no data | no data | no data | |
| Co-Founder & Chair of Scientific Advisory Board | no data | no data | 17.48% $ 99.2m | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior VP and Head of Strategy & Corporate Operations | 3.7yrs | no data | 0.15% $ 870.5k | |
| Senior VP of Finance & Chief Accounting Officer | 1.7yrs | no data | no data | |
| Chief Scientific Officer | 3.3yrs | US$1.40m | 0.84% $ 4.7m | |
| Senior Vice President of Intellectual Property & Legal Affairs | no data | no data | no data | |
| Chief Human Resources Officer | 1.8yrs | no data | no data | |
| Senior VP & Head of Regulatory Affairs | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
56yo
Average Age
Experienced Management: PRME's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$924.04k | 3.78% $ 21.5m | |
| Co-Founder & Chair of Scientific Advisory Board | 1.8yrs | no data | 17.48% $ 99.2m | |
| Independent Director | 3.7yrs | US$11.50k | 0.014% $ 79.1k | |
| Independent Director | 2.5yrs | US$164.16k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$261.68k | 0% $ 0 | |
| Independent Director | 4.7yrs | US$11.50k | no data | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
| Independent Director | 2.5yrs | US$161.66k | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
| Independent Director | 2.5yrs | US$11.88k | no data | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data |
2.5yrs
Average Tenure
63yo
Average Age
Experienced Board: PRME's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.